• SN EN ISO 10993-17 : 2009

    Superseded A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.

    BIOLOGICAL EVALUATION OF MEDICAL DEVICES - PART 17: ESTABLISHMENT OF ALLOWABLE LIMITS FOR LEACHABLE SUBSTANCES

    Available format(s): 

    Superseded date:  18-01-2024

    Language(s): 

    Published date:  12-01-2013

    Publisher:  Swiss Standards

    Sorry this product is not available in your region.

    Add To Cart

    Table of Contents - (Show below) - (Hide below)

    Foreword
    Introduction
    1 Scope
    2 Normative reference
    3 Terms and definitions
    4 General principles for establishing allowable limits
    5 Establishment of tolerable intake (TI) for specific leachable
       substances
       5.1 General
       5.2 Exposure considerations for TI calculation
       5.3 Collection and evaluation of data
       5.4 Set TI for noncancer endpoints
       5.5 Set TI for cancer endpoints
       5.6 Establishment of tolerable contact levels (TCLs)
       5.7 Risk assessment of mixtures
    6 Calculation of tolerable exposure (TE)
       6.1 General
       6.2 Exposure population
       6.3 Calculation of utilization factor from intended use pattern
       6.4 Tolerable exposure
    7 Feasibility evaluation
    8 Benefit evaluation
    9 Allowable limits
    10 Reporting requirements
    Annex A (informative) Some typical assumptions for biological
            parameters
    Annex B (informative) Risk assessment for mixtures of leachable
            substances
    Annex C (informative) Conversion of allowable limits for systemic
            exposure and for body surface contact to maximum dose to
            patient from a medical device
    Annex D (informative) Risk analysis report
    Bibliography

    Abstract - (Show below) - (Hide below)

    Describes a method for the determination of allowable limits for substances leachable from medical devices. It is intended for use in deriving standards and estimating appropriate limits where standards do not exist. It describes a systematic process through which identified risks arising from toxicologically hazardous substances present in medical devices can be quantified.

    General Product Information - (Show below) - (Hide below)

    Development Note Supersedes SN 119800. (06/2006)
    Document Type Standard
    Publisher Swiss Standards
    Status Superseded
    Superseded By
    Supersedes
    • Access your standards online with a subscription

      Features

      • Simple online access to standards, technical information and regulations
      • Critical updates of standards and customisable alerts and notifications
      • Multi - user online standards collection: secure, flexibile and cost effective